Study Summary
This protocol is to ensure consistent long-term follow-up for delayed safety events in participants who received A2 Bio gene therapy (GT) products.
Want to learn more about this trial?
Request More InfoInterventions
No additional intervention administered in this long term follow-up studyOTHER
Safety follow-up for A2 Bio GT products administered in a previous interventional study
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Mayo Clinic | Rochester | Minnesota | United States |
| NYU Langone Medical Center | New York | New York | United States |